🌩️ Anesthetic Considerations in Preeclampsia
🔷 INTRODUCTION
Preeclampsia is a multisystem hypertensive disorder of pregnancy, defined as the new onset of hypertension and end-organ dysfunction (with or without proteinuria) after 20 weeks gestation. It can progress to eclampsia, HELLP syndrome, or other life-threatening complications if not managed promptly.
It presents major anesthetic concerns due to vascular instability, altered pharmacodynamics, risk of seizures, coagulopathy, airway edema, and poor end-organ perfusion.
🔷 DEFINITION
- Hypertension in pregnancy: SBP ≥140 mmHg or DBP ≥90 mmHg on 2 occasions ≥4 hours apart after 20 weeks gestation.
- Preeclampsia: Hypertension PLUS one of the following:
- Proteinuria ≥300 mg/24 hrs or ≥1+ on dipstick,Protein to Creat Ratio_>0.3
- Platelet count <100,000/mm³
- Elevated liver enzymes (AST/ALT), right upper quadrant pain
- Renal insufficiency (serum creatinine >1.1 mg/dL)
- Pulmonary edema
- Cerebral or visual disturbances
🔹 Severe Preeclampsia
- SBP ≥160 mmHg or DBP ≥110 mmHg
- Marked end-organ dysfunction
🔹 Eclampsia
- Criteria of preeclampsia + new-onset seizures (generalized tonic-clonic)
- No pre-existing seizure disorder
🔷 ETIOPATHOGENESIS
- Abnormal trophoblastic invasion → spiral artery remodeling failure
- High-resistance uteroplacental circulation → placental hypoxia
- Endothelial dysfunction → release of vasoactive substances
- Vasospasm, capillary leak, and microthrombi → multisystem involvement
🔷 SYSTEMIC EFFECTS OF PREECLAMPSIA
|
System |
Changes |
|
CVS |
↑ SVR, ↑ BP, ↓ intravascular volume, ↑ afterload |
|
Renal |
↓ GFR, ↓ U/O, ↑ uric acid/creatinine |
|
Hematologic |
Thrombocytopenia, DIC, hemolysis |
|
Liver |
↑ AST/ALT, subcapsular hematoma, HELLP syndrome |
|
CNS |
Headache, visual changes, seizures (eclampsia), PRES |
|
Respiratory |
Pulmonary edema (capillary leak), ↓ compliance |
|
Placenta/Fetus |
Uteroplacental insufficiency, IUGR, fetal distress |
🔷 INVESTIGATIONS
- CBC: Platelets, Hb
- Liver enzymes: AST, ALT
- Renal function: Creatinine, Uric acid
- Coagulation: PT, aPTT, INR
- Urinalysis: Proteinuria (24-hour collection or dipstick)
- Fundoscopy: Retinal vasospasm
- Fetal monitoring: USG, CTG
🔷 DRUG THERAPY BEFORE DELIVERY
|
Drug |
Purpose |
Notes |
|
Magnesium Sulfate |
Seizure prophylaxis |
4 g IV bolus + 1–2 g/hr infusion; monitor for toxicity |
|
Labetalol |
BP control |
α and β blocker; IV bolus 20 mg → titrate |
|
Hydralazine |
BP control |
Arteriolar dilator; may cause reflex tachycardia |
|
Nifedipine |
Oral BP control |
Calcium channel blocker |
|
Corticosteroids |
Fetal lung maturity |
Betamethasone 12 mg IM q24h ×2 |
⚠️ Avoid NSAIDs (renal compromise), Ergot alkaloids (vasospasm)
🔷 ANESTHETIC GOALS
- Avoid sudden rise/fall in BP
- Prevent seizures
- Maintain uteroplacental perfusion
- Maintain airway patency (edema risk)
- Volume control – avoid overload (risk of pulmonary edema)
- Be ready for emergency delivery
- Ensure adequate fetal monitoring
- Be cautious with drug dosages due to altered pharmacokinetics
🔷 REGIONAL ANESTHESIA
✅ Preferred if no contraindications
🔹 Spinal Anesthesia
- Acceptable in stable, well-controlled preeclampsia
- Use reduced dose of bupivacaine (due to decreased CSF volume)
- Combine with opioids for enhanced analgesia
Contraindications: Platelet <75,000/mm³, coagulopathy, hemodynamic instability
🔹 Epidural Anesthesia
- Preferred in laboring patients
- Slower onset, better hemodynamic control
- Can be titrated for cesarean delivery if needed
🔹 Combined Spinal-Epidural (CSE)
- Useful in labor analgesia or cesarean
- Offers rapid onset and titration
🔷 GENERAL ANESTHESIA
❌ High-risk, used only when regional is contraindicated
🔹 Indications
- Eclampsia (seizing or postictal)
- Coagulopathy (low platelets)
- Emergency cesarean delivery
- Failed regional block
🔹 Considerations
- Difficult airway: Anticipate edema and poor visibility
- Rapid desaturation: Preoxygenate thoroughly
- Pressor response to laryngoscopy: Use fentanyl, esmolol, lidocaine
- Drug interaction with MgSO₄:
- Potentiates NMBs (especially non-depolarizing)
- Decreased ACh release → prolonged paralysis
- Use lower doses of muscle relaxants and monitor neuromuscular function
- Cricoid pressure, aspiration prophylaxis mandatory
🔷 INTRAOPERATIVE MONITORING
- Standard ASA monitors
- Invasive BP monitoring (ART line) for severe cases
- CVP if fluid management is challenging
- Urine output hourly (foley catheter)
- Neuromuscular monitoring if MgSO₄ is used
- Fetal monitoring (CTG) if gestational age permits
🔷 FLUID MANAGEMENT
- Preeclamptics are intravascularly dry but extracellularly overloaded
- Restrictive fluid strategy: ~75–100 mL/hr of crystalloid unless hypovolemic
- Avoid overhydration (pulmonary edema risk)
- Colloids may be considered during volume shifts (e.g., hemorrhage)
🔷 POSTOPERATIVE CARE
- Continue magnesium sulfate for 24 hours postpartum
- Monitor for seizures, pulmonary edema, PPH
- Continue BP control
- Vigilant monitoring in high-dependency or ICU setting
- Early ambulation, DVT prophylaxis
- Pain control: Epidural infusion if catheter retained
🔷 COMPLICATIONS
|
Complication |
Management |
|
Seizure (Eclampsia) |
MgSO₄, airway control, delivery |
|
Pulmonary edema |
Oxygen, diuretics, fluid restriction |
|
HELLP syndrome |
Blood products, early delivery |
|
Renal failure |
Monitor U/O, renal profile |
|
Abruptio placentae |
Resuscitate, expedite delivery |
🔹 Magnesium Sulfate Toxicity
|
Sign |
Plasma Level (mEq/L) |
|
Loss of DTR |
>5 |
|
Respiratory depression |
>10 |
|
Cardiac arrest |
>15 |
- Antidote: 10 mL of 10% Calcium Gluconate IV over 10 mins
🔷 MCQ PEARLS
|
Question |
Answer |
|
Drug of choice for seizure prophylaxis |
Magnesium sulfate |
|
Magnesium toxicity antidote |
Calcium gluconate |
|
Preferred vasopressor in preeclampsia |
Phenylephrine |
|
Platelet cutoff for spinal |
75,000/mm³ |
|
Most feared complication |
Eclampsia |
🔷 CONCLUSION
Preeclampsia is a multisystem disorder with profound anesthetic implications. Careful preoperative evaluation, choice of safe anesthesia technique (regional > GA), meticulous intraoperative management, and vigilant postoperative monitoring are critical for maternal and fetal safety. The anesthesiologist plays a central role in managing this high-risk obstetric condition.

